Literature DB >> 2597686

Immunoliposomes with different acid sensitivities as probes for the cellular endocytic pathway.

D Collins1, F Maxfield, L Huang.   

Abstract

By combining dioleoylphosphatidylethanolamine (DOPE) with oleic acid (OA), palmitoylhomocysteine (PHC) or dipalmitoylsuccinylglycerol (DPSG) we have prepared pH-sensitive liposomes with different acid sensitivities. DOPE/OA liposomes are the most acid sensitive, while DOPE/DPSG liposomes are the least acid sensitive. Incubation of DOPE/OA liposomes with mouse L929 cells reduces the pH-sensitivity of these liposomes by altering the lipid composition. Using diphtheria toxin fragment A as a marker for cytoplasmic delivery, we find that the delivery kinetics of pH-sensitive immunoliposomes closely correlates with the modified acid sensitivities of the liposomes. Immunoliposomes encounter pH 6-6.2 with a t1/2 of 5-15 min after internalization. By contrast, acidification of the endosomes to pH 5.0 takes longer (t1/2 approximately 25 min). We also used a whole cell null point technique (Yamishiro and Maxfield (1987) J. Cell Biol. 105, 2713-2721) to directly determine the average pH encountered by the endocytosed immunoliposomes. We find that acidification determined by the null point method proceeds less rapidly than that estimated from DTA delivery data. This is likely due to the fact that the measured DTA delivery is done by those liposomes which first arrive at the endosomes with sufficient acidity. Our data suggests that DOPE/PHC immunoliposomes deliver at the early endosome while DOPE/DPSG immunoliposomes deliver at the late endosomes. The DOPE/OA immunoliposomes, with the altered composition and acid sensitivity, deliver with a kinetics intermediate between the other two immunoliposomes. Thus, pH-sensitive liposomes represent useful probes for studying the kinetics of endosome acidification.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2597686     DOI: 10.1016/0005-2736(89)90453-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  Theory of tunable pH-sensitive vesicles of anionic and cationic lipids or anionic and neutral lipids.

Authors:  X Li ; M Schick
Journal:  Biophys J       Date:  2001-04       Impact factor: 4.033

2.  Targeting ischemic penumbra Part II: selective drug delivery using liposome technologies.

Authors:  Shimin Liu; Steven R Levine; H Richard Winn
Journal:  J Exp Stroke Transl Med       Date:  2011

3.  Tunable pH-sensitive liposomes composed of mixtures of cationic and anionic lipids.

Authors:  I M Hafez; S Ansell; P R Cullis
Journal:  Biophys J       Date:  2000-09       Impact factor: 4.033

4.  Immunosuppressive nano-therapeutic micelles downregulate endothelial cell inflammation and immunogenicity.

Authors:  Satish N Nadig; Suraj K Dixit; Natalie Levey; Scott Esckilsen; Kayla Miller; William Dennis; Carl Atkinson; Ann-Marie Broome
Journal:  RSC Adv       Date:  2015-04-24       Impact factor: 3.361

5.  Targeting ischemic penumbra: part I - from pathophysiology to therapeutic strategy.

Authors:  Shimin Liu; Steven R Levine; H Richard Winn
Journal:  J Exp Stroke Transl Med       Date:  2010-03-15

6.  Luteinizing hormone-releasing hormone receptor-mediated delivery of mitoxantrone using LHRH analogs modified with PEGylated liposomes.

Authors:  Yingna He; Linhua Zhang; Cunxian Song
Journal:  Int J Nanomedicine       Date:  2010-09-20

7.  Inhibition of the Friend retrovirus by antisense oligonucleotides encapsulated in liposomes: mechanism of action.

Authors:  C Ropert; C Malvy; P Couvreur
Journal:  Pharm Res       Date:  1993-10       Impact factor: 4.200

8.  Biophysical studies and intracellular destabilization of pH-sensitive liposomes.

Authors:  F Van Bambeke; A Kerkhofs; A Schanck; C Remacle; E Sonveaux; P M Tulkens; M P Mingeot-Leclercq
Journal:  Lipids       Date:  2000-02       Impact factor: 1.646

9.  Modulation of doxorubicin resistance in a doxorubicin-resistant human leukaemia cell by an immunoliposome targeting transferring receptor.

Authors:  S Suzuki; K Inoue; A Hongoh; Y Hashimoto; Y Yamazoe
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Cytotoxicity of anti-c-erbB-2 immunoliposomes containing doxorubicin on human cancer cells.

Authors:  S Suzuki; S Uno; Y Fukuda; Y Aoki; T Masuko; Y Hashimoto
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.